Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Cefaclor monohydrate

Cefaclor monohydrate

pharmaceutical raw materials
Cefaclor monohydrate structure

Cefaclor monohydrate 

structure
  • CAS No:

    70356-03-5

  • Formula:

    C15H14ClN3O4S.H2O

  • Chemical Name:

    Cefaclor monohydrate

  • Synonyms:

    5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-,hydrate (1:1),(6R,7R)-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[(aminophenylacetyl)amino]-3-chloro-8-oxo-,monohydrate,[6R-[6α,7β(R*)]]-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2R)-aminophenylacetyl]amino]-3-chloro-8-oxo-,monohydrate,(6R,7R)-;Cephaclor monohydrate;Cefaclor monohydrate;Keflor;126269-39-4

  • Categories:

    Active Pharmaceutical Ingredients  >  Antibiotics

Description

Cefaclor monohydrate is an effective antibiotic agent, and specifically binds to penicillin-binding protein 3 (PBP 3)[1].


Cefaclor is a beta-lactam, second-generation cephalosporin antibiotic with bactericidal activity. Cefaclor binds to and inactivates penicillin-binding proteins (PBP) located in bacterial cytoplasmic membranes. PBPs are enzymes involved in the terminal stages of assembling the bacterial cell wall and in reshaping the cell wall during growth and division. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis.|Semisynthetic, broad-spectrum antibiotic derivative of CEPHALEXIN.

Cefaclor monohydrate Basic Attributes

385.82

385.05000

258-909-5

69K7K19H4L

C28911

3004201500

Characteristics

139

>180°C (dec.)

778.4°C at 760 mmHg

385.2ºC

-20°C Freezer

Abdominal cavity-rat LD50: 1259 mg/kg; abdominal cavity mouse LD50: 400 mg/kg

Thermal decomposition emits toxic nitrogen oxides, sulfur oxides, chloride fumes

Safety Information

NONH for all modes of transport

2

42/43-36

22-36/37-45

XI0363000

Xn,Xi

The warehouse is low-temperature, ventilated and dry

P261-P280-P284-P304 + P340-P333 + P313-P342 + P311

H317-H334

|Warning|H319 (92.68%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]|P264, P280, P305+P351+P338, and P337+P313|Aggregated GHS information provided by 41 companies from 3 notifications to the ECHA C&L Inventory.

Toxicity

moderately toxic

Drug Information

Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)

5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-chloro-8-oxo-, (6R-(6alpha,7beta(R*)))-

Cefaclor monohydrate Use and Manufacturing

Methods of Manufacturing

With penicillin G as raw material. First protect the carboxyl group on penicillin G with p-nitrobenzyl, and then oxidize to sulfoxide with hydrogen peroxide or peroxyacetic acid. Under the action of N-chlorosuccinimide or N-chlorophosphorphthalamide, etc., chlorination and ring expansion are carried out. After ozonation and reduction, the 3 position will form a hydroxyl group. Then, under phosphorus trichloride, the 3 position is converted to chloro; then under the action of phosphorus pentachloride and pyridine, the 7 position is then alcoholylated to form the free amino acid hydrochloride, namely 7-amino-3-chloro Hydrochloride salt of p-nitrobenzyl-3-cephem-4-carboxylate. It was dissolved in a solution of tetrahydrofuran and methanol, and a 5% palladium-carbon ethanol solution was added, followed by hydrogenation at room temperature and a hydrogen pressure of 0.35 MPa for 45 minutes. Filter, the filter cake was washed with tetrahydrofuran and water. Evaporate the solvent to dryness. The residue is dissolved in a mixture of water and ethyl acetate, the Ph value is adjusted to 3, a solid is precipitated, filtered, and soaked with acetone, and then dried to be 7-amino-3-chloro-3-cephem-4-carboxylic acid . It was dissolved in acetonitrile, and N, O-bis(trimethylsilyl)acetamide was added with stirring at room temperature to form a soluble disilyl ester. Cooled to 0℃, in the presence of two drops of N, N-dimethylbenzylamine, slowly add the sodium salt of methyl 3-(β-carboxybenzylamine) crotonate and methyl chloroformate in the reaction solution of acetonitrile . The mixture was continuously stirred in an ice bath for 2h, methanol was added, and insoluble materials were removed by filtration. Add water again, adjust the Ph value to 1.5, and then adjust to 4.5 with triethylamine. Stir for another 1 h on the water bath, filter the crystalline precipitate, wash with acetonitrile, and vacuum dry to obtain cefaclor. The hydrochloride of the free amino group obtained above can be directly reacted with azidophenylacetic acid, and then hydrogenolysis can also be used to obtain cefaclor, the reaction is relatively simple.

Uses

Second-generation cephalosporin antibiotic. Antibacterial

Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients

Computed Properties

Molecular Weight:385.8
Hydrogen Bond Donor Count:4
Hydrogen Bond Acceptor Count:7
Rotatable Bond Count:4
Exact Mass:385.0499195
Monoisotopic Mass:385.0499195
Topological Polar Surface Area:139
Heavy Atom Count:25
Complexity:606
Defined Atom Stereocenter Count:3
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Drug Function and Efficacy

This product is a broad-spectrum semi-synthetic cephalosporin antibiotic. Its activity against penicillinase-producing Staphylococcus aureus, group A hemolytic streptococci, viridans streptococci and Staphylococcus epidermidis is the same as that of cefadroxil, and its antibacterial effect against non-enzyme-producing Staphylococcus aureus and pneumococci is 2 to 4 times stronger than that of cefadroxil. Its activity against Gram-negative bacilli, including Escherichia coli and Klebsiella pneumoniae, is stronger than that of cefadroxil, and is similar to that of cefadroxil. Its activity against Proteus mirabilis, Salmonella and Shigella is stronger than that of cefadroxil. 2.9 to 8 mg/L of this product can inhibit all Haemophilus influenzae, including strains resistant to ampicillin. Moraxella catarrhalis and Neisseria gonorrhoeae are very sensitive to this product. Indole-positive Proteus, Serratia, Acinetobacter and Pseudomonas aeruginosa are all resistant to this product. The mechanism of action of this product is to inhibit the synthesis of bacterial cell walls.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • ACS DOBFAR SPA

    Italy Italy
    Active
  • AUROBINDO PHARMA LTD

    India India
    Inactive
  • TEVA PHARMACEUTICALS USA INC

    United States United States
    Inactive

Recommended Suppliers of Cefaclor monohydrate

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.